GMS Biotech Awarded $105K NHLBI Grant to Validate HLA Typing Platform for Umbilical Cord Blood Screening | GenomeWeb

The National Hearth Lung and Blood Institute has awarded GMS Biotech $105,000 and given the firm access to a large repository of umbilical cord blood samples to validate the company's microarray-based human leukocyte antigen typing platform.

GMS believes the project could demonstrate the potential of its technology for use in routine newborn genotyping as well as HLA typing of umbilical cord blood for transplantation and stem cell therapy.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.